The increasing prevalence and complexity of osteoporosis mandates that heal
thcare providers take a comprehensive view of the scientific investigation,
treatment, and management of the disease. Despite recent pharmacologic adv
ances, the enhancement of quality of life for patients with osteoporosis re
mains an elusive goat. The measurement of disease-specific quality of life
in osteoporosis has recently improved with the development of three new too
ls specifically designed for this purpose. This paper provides an overview
of the newly developed questionnaires along with some suggestions for the i
mprovement of quality of life for this growing segment of the population.